CID 3058026

74406-03-4

Structural Information

Molecular Formula
C20H25N5O5S
SMILES
C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC(C4=CC(=C(C=C4)O)NS(=O)(=O)N)O
InChI
InChI=1S/C20H25N5O5S/c21-31(29,30)23-16-11-13(5-6-18(16)26)19(27)12-24-9-7-14(8-10-24)25-17-4-2-1-3-15(17)22-20(25)28/h1-6,11,14,19,23,26-27H,7-10,12H2,(H,22,28)(H2,21,29,30)
InChIKey
PSYRXQAMNDZSEL-UHFFFAOYSA-N
Compound name
3-[1-[2-hydroxy-2-[4-hydroxy-3-(sulfamoylamino)phenyl]ethyl]piperidin-4-yl]-2-oxo-1H-benzimidazole
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

447.15765 Da
Monoisotopic Mass

0.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 448.16493 198.9
[M+Na]+ 470.14687 204.3
[M-H]- 446.15037 201.7
[M+NH4]+ 465.19147 203.9
[M+K]+ 486.12081 197.9
[M+H-H2O]+ 430.15491 190.7
[M+HCOO]- 492.15585 207.2
[M+CH3COO]- 506.17150 226.1
[M+Na-2H]- 468.13232 200.2
[M]+ 447.15710 196.7
[M]- 447.15820 196.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.